Neuroinflammation and Diet: How Food Drives Brain Inflammation

TL;DR: Your brain has its own immune system — resident cells called microglia and astrocytes that mount inflammatory responses when they detect threats. When this response becomes chronic, driven by a poor diet rather than an acute infection, it damages neurons, impairs synaptic plasticity, and accelerates cognitive decline. The Western diet is a reliable trigger: high sugar, industrial trans fats, ultra-processed food, excess alcohol, and a fibre-starved gut microbiome all converge to keep the brain in a sustained inflammatory state. The antidote is not a single supplement but a dietary pattern — rich in omega-3 fatty acids, polyphenols, fermentable fibre, and oleocanthal from extra virgin olive oil — that activates the brain’s own resolution pathways. The evidence is strong enough to act on now.

Introduction

Inflammation is supposed to be protective. When a pathogen enters the body, or a tissue is injured, the immune system launches an inflammatory response — a controlled, temporary escalation of immune activity designed to neutralise the threat and initiate repair. This process is essential for survival, and the brain has its own version of it.

But something has gone wrong in the modern world. A growing body of research, spanning molecular neuroscience, epidemiology, and clinical trials, has converged on a finding that is now difficult to dispute: chronic, low-grade neuroinflammation is one of the most consistent biological features of cognitive decline, depression, brain fog, and neurodegenerative diseases including Alzheimer’s and Parkinson’s.

The critical insight — and the reason this matters for anyone who eats — is that diet is one of the most potent modulators of neuroinflammation. What you eat determines, to a measurable degree, whether your brain’s immune system stays in a protective standby mode or shifts into a sustained, tissue-damaging inflammatory state.

This article explains the biology of neuroinflammation, identifies the dietary factors that drive it, details the foods and nutrients that resolve it, and provides a practical framework grounded in current evidence.

The Biology of Neuroinflammation

Microglia: The Brain’s Resident Immune Cells

The brain was once thought to be “immune privileged” — sealed off from the body’s immune system by the blood-brain barrier. This is a half-truth. While circulating immune cells have limited access to healthy brain tissue, the brain possesses its own dedicated immune cells: microglia.

Microglia account for approximately 10-15% of all cells in the brain. In their resting state, they perform essential housekeeping functions — pruning unnecessary synapses, clearing cellular debris, and supporting neuronal health. They are constantly surveying their local environment through highly motile processes, ready to respond to any sign of damage or infection.

When microglia detect a threat — via pattern recognition receptors such as toll-like receptor 4 (TLR4) — they shift to an activated state. They retract their surveying processes, change morphology, and begin releasing pro-inflammatory mediators. In an acute scenario, this is appropriate and self-limiting. In a chronic scenario, it becomes the problem.

Astrocytes: Amplifiers of the Inflammatory Signal

Astrocytes are the most abundant glial cells in the brain. Under normal conditions, they support neurons by regulating neurotransmitter levels, maintaining the blood-brain barrier, and providing metabolic support. But when exposed to sustained inflammatory signalling from microglia — particularly via cytokines like IL-1alpha, TNF-alpha, and complement component C1q — astrocytes undergo a phenotypic shift described by Liddelow et al. (2017) in Nature.

These reactive astrocytes lose their neuroprotective functions and instead begin secreting neurotoxic factors that kill neurons and oligodendrocytes. This microglial-astrocyte cascade is now understood as a key amplification mechanism in neuroinflammatory disease.

The Cytokine Triad: TNF-alpha, IL-1beta, IL-6

Three pro-inflammatory cytokines dominate the neuroinflammation literature:

Tumour necrosis factor-alpha (TNF-alpha) is released early in the inflammatory cascade by activated microglia. It increases blood-brain barrier permeability, recruits additional immune cells, and — at chronically elevated levels — directly impairs long-term potentiation, the synaptic process that underpins learning and memory (Beattie et al., 2002).

Interleukin-1beta (IL-1beta) is produced through the NLRP3 inflammasome pathway and has been shown to suppress hippocampal neurogenesis and impair spatial memory in animal models. Elevated IL-1beta in cerebrospinal fluid is a consistent finding in Alzheimer’s disease.

Interleukin-6 (IL-6) has both pro-inflammatory and regulatory functions depending on context, but chronically elevated IL-6 is one of the most robust biomarkers of systemic inflammation. In the Whitehall II cohort study (Singh-Manoux et al., 2014), higher midlife IL-6 levels were associated with greater cognitive decline over the subsequent decade, independent of cardiovascular risk factors.

Acute vs Chronic Neuroinflammation

The distinction between acute and chronic neuroinflammation is fundamental.

Acute neuroinflammation occurs in response to a specific insult — a traumatic brain injury, an infection, or a stroke. Microglia activate, cytokines are released, damaged tissue is cleared, and the response resolves within days to weeks. This is adaptive and necessary.

Chronic neuroinflammation occurs when the inflammatory stimulus never fully resolves. Microglia remain in an activated state for months or years. The sustained release of TNF-alpha, IL-1beta, IL-6, and reactive oxygen species (ROS) creates a self-perpetuating cycle: inflammation damages neurons, which generates more debris, which further activates microglia. Heneka et al. (2015), in a comprehensive review in The Lancet Neurology, identified chronic microglial activation as a central pathological feature of Alzheimer’s disease and argued that it precedes overt neurodegeneration by years.

Diet is one of the primary determinants of whether the brain’s inflammatory state stays acute and resolves — or becomes chronic and destructive.

The Blood-Brain Barrier: Diet’s Point of Entry

The blood-brain barrier (BBB) is a selectively permeable layer of endothelial cells, pericytes, and astrocyte endfeet that controls what passes from the bloodstream into the brain. Its integrity is essential for protecting neurons from circulating toxins, pathogens, and inflammatory molecules.

A compromised BBB allows substances that should remain in the periphery — including pro-inflammatory cytokines, lipopolysaccharide (LPS), and immune cells — to enter the brain and activate microglia directly.

Diet affects BBB integrity through several mechanisms:

Hyperglycaemia and glycaemic variability. Chronically elevated blood sugar damages endothelial cells through oxidative stress and advanced glycation end product (AGE) formation. Starr et al. (2003) demonstrated that even non-diabetic hyperglycaemia is associated with increased BBB permeability in humans.

Saturated and trans fatty acids. Dietary trans fats and excessive saturated fat promote endothelial dysfunction and increase BBB permeability. Pallebage-Gamarallage et al. (2012) showed in an animal model that a diet high in saturated fat disrupted BBB tight junction proteins and increased cerebral leakage of plasma proteins.

Gut-derived endotoxins. When intestinal barrier integrity is compromised — by a low-fibre, high-UPF diet — bacterial lipopolysaccharide (LPS) leaks into the bloodstream, a process called metabolic endotoxaemia. Circulating LPS binds to TLR4 receptors on BBB endothelial cells, increasing permeability and simultaneously activating microglia upon entry into the brain (Banks & Robinson, 2010).

The BBB is not static. It is a dynamic structure that responds to dietary insults and improvements. Protecting it is one of the most important things you can do for brain health — and what you eat is a primary lever.

Dietary Drivers of Neuroinflammation

High Sugar and Refined Carbohydrates

Diets high in added sugar and refined carbohydrates are potent drivers of neuroinflammation through overlapping pathways.

First, they cause repeated postprandial glucose spikes that generate oxidative stress and activate NF-kB — the master transcription factor for inflammatory gene expression. Cherbuin et al. (2012), in a large Australian cohort study, found that higher fasting blood glucose within the normal range was associated with hippocampal atrophy and cognitive decline over four years.

Second, excess sugar drives formation of advanced glycation end products (AGEs), which bind to their receptor (RAGE) on microglia and endothelial cells, triggering sustained inflammatory signalling. The RAGE pathway is heavily implicated in Alzheimer’s pathology.

Third, high sugar intake alters gut microbiome composition in ways that reduce short-chain fatty acid production and increase intestinal permeability — compounding the inflammatory burden through the LPS translocation pathway described above.

Trans Fats

Industrial trans fats — found in partially hydrogenated oils, many margarines, and a range of ultra-processed baked goods — are among the most directly neurotoxic dietary components identified in research.

A landmark analysis from the Nurses’ Health Study (Devore et al., 2009) found that higher trans fat intake was associated with worse cognitive decline over a six-year period. Mechanistically, trans fats incorporate into cell membranes (including neuronal membranes), disrupting fluidity and receptor function. They also directly activate TLR4 signalling, the same pathway triggered by bacterial endotoxin.

While regulatory action has reduced trans fat in the food supply in some countries, they are still present in many processed and fast-food products, particularly in regions with less stringent food labelling requirements.

Ultra-Processed Food

Ultra-processed foods (UPFs) drive neuroinflammation through multiple reinforcing mechanisms. They are typically high in refined carbohydrates, industrial seed oils rich in omega-6 fatty acids, emulsifiers that disrupt intestinal barrier integrity, and additives that alter the gut microbiome.

Goncalves et al. (2023), in data from the ELSA-Brasil cohort of nearly 11,000 participants, found that consuming more than 20% of daily calories from UPF was associated with a 28% faster rate of cognitive decline over eight years. The proposed mechanisms are not speculative — they align with the inflammatory pathways described throughout this article: microglial activation, BBB disruption, and gut-derived endotoxaemia.

The combination of multiple pro-inflammatory ingredients in a single dietary pattern makes UPF-heavy diets particularly damaging. The effect is not simply additive — these mechanisms interact and amplify each other.

Excess Alcohol

Moderate to heavy alcohol consumption is a well-established driver of neuroinflammation. Ethanol crosses the BBB freely and directly activates microglial TLR4 receptors, triggering the release of TNF-alpha, IL-1beta, and IL-6 (Alfonso-Loeches et al., 2010). This is independent of liver damage — the neuroinflammatory effect is direct.

Additionally, alcohol disrupts gut barrier integrity, increasing LPS translocation. Leclercq et al. (2014) demonstrated in a human study that even short-term heavy drinking significantly increased intestinal permeability and circulating endotoxin levels, with corresponding elevations in markers of systemic inflammation.

The effect is dose-dependent. While the neuroinflammatory consequences are most severe in heavy drinkers, there is no evidence of a neuroinflammatory “safe zone” — even moderate consumption has been associated with measurable brain volume reductions in the UK Biobank (Topiwala et al., 2022).

Gut Dysbiosis and LPS Translocation

The gut-brain inflammatory axis deserves particular emphasis because it explains how food choices made in the intestine can trigger immune responses in the skull.

A healthy gut microbiome — diverse, fibre-fed, and dominated by commensal species — produces short-chain fatty acids (SCFAs) that maintain intestinal barrier integrity and exert anti-inflammatory effects systemically. A dysbiotic microbiome — one starved of fibre, overexposed to emulsifiers and artificial sweeteners, and lacking in microbial diversity — fails to maintain the intestinal barrier.

The consequence is metabolic endotoxaemia: lipopolysaccharide from gram-negative gut bacteria leaks through the compromised intestinal wall into the bloodstream. LPS is one of the most potent activators of the innate immune system. At the blood-brain barrier, it binds to TLR4 receptors and increases permeability. Within the brain, it activates microglia into a sustained inflammatory state.

Cani et al. (2007) demonstrated that a high-fat, low-fibre diet doubled circulating LPS levels in mice and that this metabolic endotoxaemia was sufficient to induce systemic and central inflammation. Human studies have since confirmed that circulating LPS correlates with inflammatory markers, insulin resistance, and cognitive impairment.

Dietary Solutions: Resolving Neuroinflammation

The brain is not defenceless against inflammation. It possesses active resolution pathways — biochemical mechanisms that terminate the inflammatory response and restore tissue homeostasis. Critically, many of these pathways are dependent on dietary substrates.

Omega-3 Fatty Acids: Resolvins and Protectins

The long-chain omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), found predominantly in fatty fish, are not merely anti-inflammatory in a passive sense. They are enzymatically converted into a class of bioactive lipid mediators called specialised pro-resolving mediators (SPMs) — including resolvins, protectins, and maresins.

Serhan and colleagues, in a series of landmark studies (Serhan et al., 2002; Serhan, 2014), identified these SPMs and demonstrated that they actively terminate inflammatory responses by inhibiting neutrophil infiltration, promoting macrophage clearance of debris, and restoring tissue integrity. Protectin D1, derived from DHA, has been shown to reduce microglial activation, decrease pro-inflammatory cytokine production, and promote neuronal survival in animal models of neuroinflammation (Lukiw et al., 2005).

DHA also constitutes approximately 40% of polyunsaturated fatty acids in brain cell membranes (for a deeper look at dosing and sources, see our omega-3 and brain health guide). Adequate DHA status is required for optimal membrane fluidity and receptor function — including the function of receptors involved in resolving inflammation.

The VITAL-DEP trial and other large-scale studies suggest that the neuroprotective benefits of omega-3s are most evident when baseline intake is low — which it is for the majority of adults in Western countries who consume fewer than two servings of fatty fish per week.

Polyphenols: Direct Microglial Modulation

Polyphenols — a diverse class of plant compounds found in berries, dark chocolate, green tea, turmeric, and colourful vegetables — exert anti-neuroinflammatory effects through multiple pathways.

Curcumin, the primary polyphenol in turmeric, has been shown to inhibit NF-kB activation, reduce microglial production of TNF-alpha and IL-6, and promote microglial phagocytosis of amyloid-beta in cell culture and animal models (Cole et al., 2007). Its low oral bioavailability has limited clinical translation, but dietary intake as part of a spice-rich cooking pattern still contributes to overall polyphenol exposure.

Flavonoids from berries — particularly anthocyanins — have been linked to reduced neuroinflammation in both animal models and human studies. The Nurses’ Health Study found that higher intake of blueberries and strawberries was associated with slower cognitive decline, with an estimated delay in cognitive ageing of up to 2.5 years in the highest-intake group (Devore et al., 2012).

Epigallocatechin-3-gallate (EGCG) from green tea inhibits microglial activation and reduces ROS production in neuroinflammation models. A meta-analysis by Kakutani et al. (2019) found that regular green tea consumption was associated with a lower risk of cognitive impairment in observational studies.

Fibre and Short-Chain Fatty Acid Production

Dietary fibre is the primary fuel source for beneficial gut bacteria that produce short-chain fatty acids — butyrate, propionate, and acetate. These SCFAs are central to both gut barrier integrity and neuroinflammatory regulation.

Butyrate is particularly important. It strengthens tight junctions in the intestinal epithelium (reducing LPS translocation), modulates immune cell activity toward anti-inflammatory phenotypes, and crosses the blood-brain barrier, where it inhibits histone deacetylase (HDAC) enzymes. HDAC inhibition by butyrate upregulates expression of brain-derived neurotrophic factor (BDNF) and reduces microglial inflammatory signalling (Stilling et al., 2016).

The practical implication is direct: a high-fibre diet — rich in legumes, whole grains, vegetables, nuts, and seeds — supports a microbial community that generates anti-inflammatory metabolites with direct effects on brain immune function. Conversely, a low-fibre diet starves these bacteria, reduces SCFA production, and leaves the intestinal barrier vulnerable to endotoxin leakage.

Most adults in Western countries consume 15-18 grams of fibre per day, well below the 30-40 grams associated with optimal microbiome function. Closing this gap is one of the most impactful dietary changes for reducing neuroinflammation.

Extra Virgin Olive Oil: Oleocanthal and Beyond

Extra virgin olive oil (EVOO) deserves a specific mention because it contains oleocanthal — a phenolic compound with a remarkable pharmacological profile. Oleocanthal shares the same mechanism of action as ibuprofen: it inhibits cyclooxygenase (COX) enzymes, the same targets blocked by non-steroidal anti-inflammatory drugs (Beauchamp et al., 2005).

The “ibuprofen-like” sting you feel at the back of the throat when consuming fresh, high-quality EVOO is caused by oleocanthal stimulating the same TRPA1 receptor that responds to ibuprofen. Beauchamp and colleagues estimated that a typical dietary dose of EVOO (50 mL per day) provides oleocanthal equivalent to roughly 10% of a standard ibuprofen dose — a modest but sustained anti-inflammatory exposure consumed daily for decades in Mediterranean populations.

Beyond oleocanthal, EVOO provides oleuropein and hydroxytyrosol — additional polyphenols that reduce oxidative stress, inhibit NF-kB, and protect LDL cholesterol from oxidation. The PREDIMED trial (Valls-Pedret et al., 2015), a large randomised controlled trial, found that supplementation with EVOO (1 litre per week to the household) was associated with significantly better cognitive function compared to a low-fat control diet over a median follow-up of 4.1 years.

Western Diet vs Mediterranean Diet: A Natural Experiment

The contrast between the Western dietary pattern and the Mediterranean dietary pattern provides something close to a natural experiment in neuroinflammation.

The Western diet — characterised by high intake of refined sugar, red and processed meat, ultra-processed foods, refined grains, and low intake of fruit, vegetables, legumes, and fish — consistently increases circulating markers of inflammation. Myles (2014) reviewed the evidence and concluded that the Western diet activates the innate immune system, promotes NF-kB signalling, and sustains chronic low-grade inflammation.

The Mediterranean diet — centred on vegetables, fruits, legumes, whole grains, nuts, olive oil, and fish, with moderate red wine and low consumption of processed food — has the opposite profile. Bonaccio et al. (2017) demonstrated in the Moli-sani cohort that higher adherence to the Mediterranean diet was associated with lower circulating levels of C-reactive protein, TNF-alpha, and IL-6.

For the brain specifically, the evidence is compelling. A systematic review by Loughrey et al. (2017) of twelve studies covering over 38,000 participants found that greater adherence to the Mediterranean diet was associated with reduced risk of cognitive impairment and dementia. The PREDIMED-NAVARRA randomised trial (Martinez-Lapiscina et al., 2013) directly demonstrated that a Mediterranean diet supplemented with either EVOO or mixed nuts produced better cognitive outcomes than a low-fat control diet over 6.5 years of follow-up.

These findings are consistent with what the mechanistic evidence predicts: a dietary pattern that simultaneously reduces pro-inflammatory inputs (refined sugar, trans fats, UPF) while increasing anti-inflammatory substrates (omega-3s, polyphenols, fibre, oleocanthal) should produce measurable reductions in neuroinflammation — and that is exactly what is observed.

Biomarkers: Measuring Neuroinflammation

For those interested in tracking their inflammatory status, several biomarkers are available through standard clinical testing:

High-sensitivity C-reactive protein (hs-CRP) is the most widely available marker of systemic inflammation. While not specific to neuroinflammation, elevated hs-CRP (above 3.0 mg/L) has been associated with worse cognitive outcomes in multiple cohort studies. It is a reasonable proxy for overall inflammatory burden.

Interleukin-6 (IL-6) is a more specific marker that is sometimes available through specialised testing. Chronically elevated IL-6 is one of the most consistent predictors of cognitive decline in longitudinal studies.

Fasting insulin and HOMA-IR (homeostatic model assessment for insulin resistance) are indirect markers. Insulin resistance is tightly coupled with systemic inflammation, and elevated fasting insulin often reflects a dietary pattern that promotes neuroinflammation.

Omega-3 index — the percentage of EPA and DHA in red blood cell membranes — reflects long-term omega-3 status. An index below 4% is associated with higher inflammatory risk; an index above 8% is considered optimal.

These biomarkers cannot directly measure microglial activation (that requires PET imaging with TSPO ligands, a research tool not available clinically), but they provide useful, actionable feedback on dietary interventions.

Practical Takeaway: A Framework for Reducing Neuroinflammation Through Diet

1. Eat fatty fish at least twice per week — salmon, mackerel, sardines, anchovies, or herring. This provides the EPA and DHA substrate needed for resolvin and protectin production. If you do not eat fish, an algae-based omega-3 supplement providing at least 500 mg combined EPA/DHA is a reasonable alternative.

2. Use extra virgin olive oil as your primary cooking and dressing fat. Choose high-quality, fresh EVOO — the kind that produces a peppery sting at the back of the throat, indicating oleocanthal content. Aim for 2-4 tablespoons daily.

3. Consume at least 30 grams of fibre per day from diverse sources: legumes, vegetables, whole grains, nuts, seeds, and fruit. This supports SCFA production and gut barrier integrity, reducing the LPS translocation that drives neuroinflammation.

4. Eat polyphenol-rich foods daily. Berries (especially blueberries), dark leafy greens, dark chocolate (70%+ cacao), green tea, turmeric, and colourful vegetables should be dietary staples, not occasional additions.

5. Minimise ultra-processed food. Replace packaged snacks, sugary drinks, processed meats, and industrial baked goods with whole-food alternatives. The goal is not perfection — it is meaningful reduction.

6. Limit added sugar. Keep added sugar intake below 25 grams per day. This is not about fear of glucose — your brain needs glucose. It is about avoiding the chronic glycaemic variability and AGE formation that sustain NF-kB activation.

7. If you drink alcohol, keep it minimal. The neuroinflammatory effects of alcohol are dose-dependent with no clear safe threshold. If you choose to drink, keep consumption to fewer than 7 standard drinks per week and avoid binge episodes.

8. Support your gut microbiome. In addition to fibre, include fermented foods — yoghurt, kefir, sauerkraut, kimchi — which provide live microbial diversity and have been shown to reduce systemic inflammatory markers (Wastyk et al., 2021).

This is not a supplement protocol or a short-term intervention. It is a sustained dietary pattern — one that the evidence suggests can meaningfully shift your brain’s inflammatory status over weeks to months.

FAQ

Can neuroinflammation be reversed, or is the damage permanent?

Chronic neuroinflammation is not an irreversible state. The brain possesses active resolution mechanisms — mediated by resolvins, protectins, and anti-inflammatory cytokines like IL-10 — that can terminate sustained inflammatory responses when given the appropriate substrates and stimuli. Dietary interventions have been shown to reduce circulating inflammatory markers within weeks. The PREDIMED trial, for example, demonstrated measurable reductions in inflammatory biomarkers and cognitive improvements within the intervention period. However, the extent of reversibility depends on duration and severity — early intervention is more effective than waiting until neurodegenerative damage is advanced.

How quickly do dietary changes affect neuroinflammation?

Systemic inflammatory markers such as hs-CRP and IL-6 can begin to shift within two to four weeks of meaningful dietary change. Gut microbiome composition starts shifting within days, though stable remodelling typically takes four to twelve weeks. Cognitive effects, which depend on downstream processes including BBB repair and synaptic recovery, generally take longer — most intervention studies show measurable cognitive improvements after three to six months. Consistency matters more than perfection.

Are anti-inflammatory supplements a good substitute for dietary changes?

No. Curcumin, fish oil, and resveratrol supplements have all shown anti-inflammatory effects in isolation, but they cannot compensate for an otherwise pro-inflammatory diet. A curcumin capsule taken alongside a meal of ultra-processed food is fighting the wrong battle. Supplements may have a role in augmenting a good dietary foundation — particularly fish oil for people who do not eat fatty fish — but they are not a replacement for the comprehensive, multi-pathway anti-inflammatory effect of a whole-food dietary pattern.

Is neuroinflammation the same as brain fog?

Brain fog is a symptom — characterised by difficulty concentrating, mental fatigue, and slowed processing speed — not a diagnosis. Neuroinflammation is one plausible biological mechanism underlying many cases of brain fog, particularly when it is chronic and diet-related. However, brain fog can also result from sleep deprivation, thyroid dysfunction, medication side effects, and other causes. If you experience persistent brain fog, addressing diet is a reasonable first step, but it should not replace medical evaluation if symptoms are severe or persistent.

Does the ketogenic diet reduce neuroinflammation?

There is evidence that ketogenic diets can reduce neuroinflammation through several mechanisms: beta-hydroxybutyrate (BHB) inhibits the NLRP3 inflammasome, reduces ROS production, and acts as an HDAC inhibitor. However, the quality of the fat sources matters enormously. A ketogenic diet built on processed meats, industrial oils, and cheese may reduce glucose-driven inflammation while increasing other inflammatory inputs. The anti-inflammatory benefits of ketosis are best realised when the diet emphasises fatty fish, olive oil, nuts, and non-starchy vegetables — essentially a Mediterranean-ketogenic hybrid.

Sources

• Alfonso-Loeches, S., et al. (2010). Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage. Journal of Neuroscience, 30(24), 8285-8295.
• Banks, W.A. & Robinson, S.M. (2010). Minimal penetration of lipopolysaccharide across the murine blood-brain barrier. Brain, Behavior, and Immunity, 24(1), 102-109.
• Beauchamp, G.K., et al. (2005). Ibuprofen-like activity in extra-virgin olive oil. Nature, 437(7055), 45-46.
• Beattie, E.C., et al. (2002). Control of synaptic strength by glial TNF-alpha. Science, 295(5563), 2282-2285.
• Bonaccio, M., et al. (2017). Mediterranean diet, dietary polyphenols and low-grade inflammation: results from the Moli-sani study. British Journal of Clinical Pharmacology, 83(1), 107-113.
• Cani, P.D., et al. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes, 56(7), 1761-1772.
• Cherbuin, N., et al. (2012). Higher normal fasting plasma glucose is associated with hippocampal atrophy: the PATH Study. Neurology, 79(10), 1019-1026.
• Cole, G.M., et al. (2007). Neuroprotective effects of curcumin. Advances in Experimental Medicine and Biology, 595, 197-212.
• Devore, E.E., et al. (2009). Dietary fat intake and cognitive decline in women with type 2 diabetes. Diabetes Care, 32(4), 635-640.
• Devore, E.E., et al. (2012). Dietary intakes of berries and flavonoids in relation to cognitive decline. Annals of Neurology, 72(1), 135-143.
• Goncalves, N.G., et al. (2023). Association between consumption of ultraprocessed foods and cognitive decline. JAMA Neurology, 80(2), 142-150.
• Heneka, M.T., et al. (2015). Neuroinflammation in Alzheimer’s disease. The Lancet Neurology, 14(4), 388-405.
• Kakutani, S., et al. (2019). Green tea intake and risks for dementia, Alzheimer’s disease, mild cognitive impairment, and cognitive impairment: a systematic review. Nutrients, 11(5), 1165.
• Leclercq, S., et al. (2014). Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proceedings of the National Academy of Sciences, 111(42), E4485-E4493.
• Liddelow, S.A., et al. (2017). Neurotoxic reactive astrocytes are induced by activated microglia. Nature, 541(7638), 481-487.
• Loughrey, D.G., et al. (2017). The impact of the Mediterranean diet on the cognitive functioning of healthy older adults: a systematic review and meta-analysis. Advances in Nutrition, 8(4), 571-586.
• Lukiw, W.J., et al. (2005). A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. Journal of Clinical Investigation, 115(10), 2774-2783.
• Martinez-Lapiscina, E.H., et al. (2013). Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. Journal of Neurology, Neurosurgery & Psychiatry, 84(12), 1318-1325.
• Myles, I.A. (2014). Fast food fever: reviewing the impacts of the Western diet on immunity. Nutrition Journal, 13, 61.
• Pallebage-Gamarallage, M., et al. (2012). Restoration of dietary-fat induced blood-brain barrier dysfunction by anti-inflammatory lipid-modulating agents. Lipids in Health and Disease, 11, 117.
• Serhan, C.N., et al. (2002). Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. Journal of Experimental Medicine, 196(8), 1025-1037.
• Serhan, C.N. (2014). Pro-resolving lipid mediators are leads for resolution physiology. Nature, 510(7503), 92-101.
• Singh-Manoux, A., et al. (2014). Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife. Neurology, 83(6), 486-493.
• Starr, J.M., et al. (2003). Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. Journal of Neurology, Neurosurgery & Psychiatry, 74(1), 70-76.
• Stilling, R.M., et al. (2016). The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis? Neurochemistry International, 99, 110-132.
• Topiwala, A., et al. (2022). No safe level of alcohol consumption for brain health: observational cohort study of 25,378 UK Biobank participants. Nature Communications, 13, 3580.
• Valls-Pedret, C., et al. (2015). Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Internal Medicine, 175(7), 1094-1103.
• Wastyk, H.C., et al. (2021). Gut-microbiota-targeted diets modulate human immune status. Cell, 184(16), 4137-4153.